Elbit Medical Technologies Ltd (EMTC-M.TA)
Elbit Medical Technologies Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Petah Tikva, IL. The stock last traded at $22.20, down 7.50% on the session, giving a market capitalisation of $20.1M. Its beta of 0.19 implies it has historically moved less than the broad market.
Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.
Elbit Medical Technologies Ltd is most often compared with the following Healthcare names: